Treating hepatitis C: can you teach old dogs new tricks?

Hepatology. 2005 Dec;42(6):1455-8. doi: 10.1002/hep.20975.

Abstract

Viruses depend on host-derived factors for their efficient genome replication. Here, we demonstrate that a cellular peptidyl-prolyl cis-trans isomerase (PPIase), cyclophilin B (CyPB), is critical for the efficient replication of the hepatitis C virus genome. CyPB interacted with the HCV RNA polymerase NS5B to directly stimulate its RNA binding activity. Both the RNA interference (RNAi)-mediated reduction of endogenous CyPB expression and the induced loss of NS5B binding to CyPB decreased the levels of HCV replication. Thus, CyPB functions as a stimulatory regulator of NS5B in HCV replication machinery. This regulation mechanism for viral replication identifies CyPB as a target for antiviral therapeutic strategies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Cyclophilins / physiology*
  • Cyclosporine / metabolism
  • Cyclosporine / pharmacology
  • Hepacivirus / drug effects
  • Hepatitis C / drug therapy*
  • Humans
  • Peptidylprolyl Isomerase / physiology*
  • RNA, Viral / biosynthesis
  • Viral Nonstructural Proteins / physiology*
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • RNA, Viral
  • Viral Nonstructural Proteins
  • cyclophilin B
  • Cyclosporine
  • NS-5 protein, hepatitis C virus
  • Cyclophilins
  • Peptidylprolyl Isomerase